OHGR LSE Week ended 07 Aug 2026

Weekly Investor Report

One Health Group Plc · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 285.0 GBP
3.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 14.9% above the Trend Line and sits at 94.0% of its 52-week range. The latest completed week returned 3.6%, after a 15.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.

Setup score 71 out of 100
Latest Close 285.0 GBP 7 Aug 2026
1W Return 3.6% latest completed week
4W Return 15.2% short-term follow-through
12W Return 13.3% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • The trend backdrop is active with a 18-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 36.44% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.6% Latest completed week; four-week move 15.2%. Indicator stack 81/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 36.44% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 5 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 14.9% above the Trend Line and sits at 94.0% of its 52-week range. The latest completed week returned 3.6%, after a 15.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 13 Mar 20 Mar 27 Mar 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5812-week average 0.68

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 15.2% over four weeks, 13.3% over 12 weeks, and 12.2% over one year. The current trend has remained active for 18 consecutive weeks.

Performance by holding period

1W3.6%
4W15.2%
12W13.3%
26W14.0%
52W12.2%
Active trend streak18 weeks
Active weeks in one year34
Trend breadth65.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.26Latest activity-pressure read.
Pressure change215.0%Four-week change in activity pressure.
Leadership6.19Latest relative-leadership reading.
RS change227.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength6/100Blend of value, momentum, and quality. Underlying universe rank 95; rank 1 is best.
Value12/100Relative valuation strength. Underlying universe rank 89; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum19/100Medium-term price momentum. Underlying universe rank 82; rank 1 is best.
Growth95/100Revenue and earnings growth. Underlying universe rank 6; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework73/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.5x
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
9.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
20.5%
Gross profit retained from each unit of revenue.
Operating margin
7.4%
Operating profit retained from revenue.
Free-cash-flow margin
0.3%
Free cash flow generated from revenue.
Return on invested capital
58.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
11.3%
Latest one-year revenue growth.
EPS growth
91.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-92.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.2%
Cash dividends relative to market value.
Buyback yield
-0.4%
Net share repurchases relative to market value.
Shareholder yield
1.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 5 relevant articles.

0 positive · 5 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.7%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 268 weeks finished lower.
Best week+10.0%Week of 31 Jul.
Worst week-7.1%Week of 6 Feb.
Latest week+3.6%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains8
Flat weeks6
Modest losses6
Sharp losses2
Recent vol2.9%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split22/21Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryGB Medical Care Facilities
4-week rank1 / 3
Group average9.5%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD100.0%positive activity pressure
RS66.7%positive relative leadership

Four-week leaders

OHGR · LSE15.2%SPI · LSE8.1%CVSG · LSE5.2%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape68/100

Trend, activity pressure, participation, and risk combine to a 68/100 tape read.

 Indicator analysis55/100

Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 2/12.

Activity pressure 0.58; 2 reversal markers Next-Week ExpectancyNegative 36.44%

Next-week expectancy is negative with a 36.44% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors12/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 91; Small Cap Core rank 81 SVQF73/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 71.5 of 260 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 5 relevant articles.

REG - One Health Group PLC - Holding(s) in Company Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026285.0 GBP3.6%248.1 GBP233.6 GBP0.266.1989.9KOn
31 Jul 2026275.0 GBP10.0%247.0 GBP232.8 GBP0.132.64135.7KOn
24 Jul 2026250.0 GBP0.6%246.2 GBP232.2 GBP-0.13-5.5565.0KOn
17 Jul 2026248.5 GBP0.4%246.2 GBP231.9 GBP-0.17-5.1051.7KOn
10 Jul 2026247.5 GBP2.1%246.2 GBP231.7 GBP-0.22-4.84344.7KOn
3 Jul 2026242.5 GBP-1.8%245.8 GBP231.4 GBP-0.18-8.4524.6KOn
26 Jun 2026247.0 GBP0.0%245.3 GBP231.3 GBP-0.02-5.01700On
19 Jun 2026247.0 GBP-1.8%244.7 GBP231.0 GBP0.12-3.39761On
12 Jun 2026251.5 GBP0.0%244.5 GBP230.7 GBP0.35-2.337.5KOn
5 Jun 2026251.5 GBP0.0%244.0 GBP230.4 GBP0.32-1.1013.2KOn
29 May 2026251.5 GBP0.0%243.0 GBP230.1 GBP0.22-1.247.5KOn
22 May 2026251.5 GBP0.0%242.1 GBP229.7 GBP0.17-1.5330.6KOn
15 May 2026251.5 GBP1.2%241.6 GBP229.3 GBP-0.121.3223.4KOn
8 May 2026248.5 GBP-0.8%241.1 GBP228.9 GBP-0.31-0.0731.7KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context